Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Diseases

Explore clinical trials studying Biliary Tract Diseases. Study availability and eligibility vary by location and protocol.

1,498 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Diseases trial results

Active, Not Recruiting

Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

NCT06553768

Conditions
Bile Duct Diseases, Biliary Atresia, Biliary Tract Diseases, +13 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Stanford Children's Health in Palo Alto Palo Alto, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

NCT06178445

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Charité Universitätsmedizin Berlin, Germany
  • Krankenhaus Nordwest (KHNW) Frankfurt, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Active, Not Recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capitai Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 16 locations
View Trial Details
Active, Not Recruiting

CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)

NCT05896137

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Captail Medcial University Beijing, Beijing Municipality, China
  • Beijing YouAn Hostital, Captial Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

NCT04663308

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +10 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 103 locations
View Trial Details

Related conditions